Effects of Apatinib Mesylate Monotherapy on the Incidence of Adverse Reactions and Immune Function in Patients with Breast Cancer after Radical Mastectomy.
Evid Based Complement Alternat Med
; 2022: 4022282, 2022.
Article
en En
| MEDLINE
| ID: mdl-35990841
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Incidence_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Evid Based Complement Alternat Med
Año:
2022
Tipo del documento:
Article
País de afiliación:
China